Brooklyn-based company’s bleach paint wins Lafayette’s medical pitch competition

0


[ad_1]

A Brooklyn startup leaves Lafayette $ 40,000 richer after taking home two prizes in Innovate South’s Get Started Medical Pitch competition.

Kinnos, a company that developed a product that stains bleach blue, won both prizes in the fourth virtual pitch competition. The company won the US $ 10,000 Audience Award and the US $ 30,000 Jury Prize.

Kinnos was chosen from seven finalists, all of which made and did two and a half minute presentations, plus a question-and-answer session with a jury. The company uses a product called Highlight to dye bleach and bleaching cloths blue so people who disinfect can see if they missed stains.

Latest:Louisiana is looking back at the fourth wave of COVID-19 as hospital admissions hit a record low

“Currently cleaning is done by the least paid workers who are in a hurry and need a quick turnaround,” said Rachael Sparks, vice president of marketing at Kinnos. “This problem is compounded by the fact that it is invisible. All disinfectants are invisible.”

Kinnos sells an attachment that fits on the top of a bleach container. If a cloth is pulled through the attachment, the bleach will turn blue. Anything wiped off with the wipe will turn blue and the color will fade after a few minutes.

The product is designed to fill any training gaps or language barriers that exist on many hospital cleaning teams, Sparks said. It’s also cheaper and less time consuming than other products on the market, such as UV lamps.

Coronavirus cleaning:Tips for your phone, tablet and other devices

The company sells four units including cartridges for $ 1,500. A refill of 20 cartridges sells for $ 600. The company also has an option for liquid bleach.

The product is used in 11 hospitals and veterans affairs medical centers, Sparks said.

In the United States, one in 31 hospitalized patients will develop a hospital-associated infection. It is one in three in developing countries.

“We’d like to cut that in half,” said Sparks.

What were the other entries?

Kinnos beat six other companies for the money, including Crosscope of Mountain View, California; General Genomics from Midland, Texas; NEVAP of San Jose, California; Protean BioDiagnostics of Orlando, Florida; SafeBVM of Chesterfield, Missouri; and Prep Tech from Lafayette.

Lafayette-based Prep Tech unveiled its ULTRAPREP product, a preoperative skin preparation system outside of the operating room that allows more efficient use of procedure time. The process involves placing the limb in a safety sheath and applying antiseptics.

Pete Prados, Chief Operating Officer of Prep Tech, compared the ULTRAPREP to the Shake ‘n Bake food product – you put the limb in the sheath and let the antiseptic coat it.

Crosscope, short for Computational Microscope, uses artificial intelligence to help doctors make accurate cancer diagnoses and improve patient outcomes.

General Genomics has developed a platform called Curo46 that helps determine a person’s health risks, appropriate preventive measures, tailored treatment programs, and more.

California-based NEVAP makes breathing tubes that remove pathogens, which can reduce mechanical ventilation time, reduce treatment costs, and reduce patient mortality.

Protean BioDiagnostics has developed a cancer diagnostic service called Oncology MAPS. The system uses the highest quality tests and can be tailored precisely to a cancer patient’s needs during treatment.

SafeBVM adds an accessory called SIP Safety Accessory to the bag valve mask that makes emergency airway management safer. The attachment ensures that the airflow generated when the bag is pumped is optimal and safe.

[ad_2]

Leave A Reply

Your email address will not be published.